Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|December 17, 2013
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signalingJuan L García-Rodríguez, Lucía Barbier-Torres, Sara Fernández-Álvarez, et al.
The American Journal of Clinical Nutrition|December 5, 2019
Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjectsSabina Smajis, Martin Gajdošík, Lorenz Pfleger, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trialStefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.
Journal of Hepatology|May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitisPeter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Hepatology (Baltimore, Md.)|May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Hepatology International|June 2, 2021
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver diseaseRafael Paternostro, Katharina Staufer, Stefan Traussnigg, et al.
Toxicology Letters|August 13, 2022
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assayTim Brecklinghaus, Wiebke Albrecht, Julia Duda, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Gut|March 3, 2025
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting TH17 pathogenicity and transdifferentiationCi Zhu, Nicole Boucheron, Osamah Al-Rubaye, et al.
Journal of Hepatology|July 9, 2021
24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammationCi Zhu, Nicole Boucheron, André C Müller, et al.
Pageof 8